Predictors of PPI Response in Eosinophilic Esophagitis.
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 18 Apr 2012
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Eosinophilic oesophagitis
- Focus Therapeutic Use
- 18 Apr 2012 Actual initiation date changed from Jan 2012 to Mar 2012 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Planned end date changed from 1 Dec 2013 to 1 Mar 2012 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.